Dr. Rachna Shroff, a renowned bile duct cancer researcher, died at 47 from the aggressive disease she spent her career trying to defeat.
The University of Arizona announced on Monday that Shroff had died from an aggressive cancer after a diagnosis earlier this year. Once the disease spread, doctors confirmed it as terminal adenocarcinoma, a cancer that attacks the glands lining organs.
Daily Mail reported that she leaves her husband, Dr. Puneet Shroff, and their children, Simran and Sachin. Colleagues described a physician who never stopped pushing new options for patients even as her own illness advanced.
Shroff served as associate director of clinical investigations at the University of Arizona Cancer Center and as chief of the Division of Hematology/Oncology in the Department of Medicine at the College of Medicine, Tucson. She joined the university in 2018 after earlier faculty work at MD Anderson Cancer Center.
The university called her an internationally recognized expert in bile duct cancer, or cholangiocarcinoma. She focused on the rare and historically difficult-to-treat disease when few options existed and no Food and Drug Administration-approved therapies were available.
Today the field looks different, the university said, due in part to landmark clinical trials she led as a principal investigator. She advanced immunological therapies and novel drug treatments, authored more than 80 publications, and delivered over 130 talks. A fellow at the American Society of Clinical Oncology described her as one of the foremost experts on pancreatic and biliary tract cancers.
Her interest in research began in high school. She won the Osler Fellowship in 1993 and, as the university put it, knew she wanted to meld scientific discovery with her innate sense of compassion while never losing sight of the human side of medicine.
Young adults facing sudden cancer diagnoses have drawn public attention in other recent cases, including a Louisiana musician’s unexpected prostate cancer finding during a routine physical.
Diagnosed earlier this year, Shroff still established the Conquer Cancer, Rachna Shroff Endowed Young Investigator Award in Biliary Cancers in September. Within weeks, and in the face of her own life-limiting cancer, she raised more than $1.35 million to support future cancer innovation.
In 2024 she told GIOncology Now what drove her approach to patients.
"It is our role and responsibility to have clinical trials available to the patients that come to see us and to ideally have a trial available to every single patient that walks through the door. To be able to offer them something cutting-edge, different and innovative."
The Cholangiocarcinoma Foundation, where she served on the Science and Medical Advisory Board, posted a tribute noting that she helped build one of the nation’s largest clinical and research programs in biliary tract cancer during her time at MD Anderson and remained an empathetic clinician throughout.
"Whether she was quoting Beyoncé in a talk about clinical trials or getting us to throw our hands during her amazing Bollywood lesson, Rachna made us live in the moment and laugh, even in the hardest of times. Our hearts are with her family and friends in the days ahead and beyond."
Aggressive cancers have also claimed other young lives in public service, among them a Texas DPS special ops sergeant who died at 29 after a brain cancer battle.
Colleague Lisa Salem Craine called Shroff brilliant, kind, and compassionate. She recalled watching Shroff teach 600 patients, caregivers, researchers, physicians, and industry leaders how to Bollywood dance.
"That was Rachna, bringing people together, spreading joy, and lighting up every room she entered. Her contributions to bile duct cancer research and the lives she touched will never be forgotten."
The foundation added that she brought fun everywhere she went and made tangible differences for patients and families in every facet of her work. The university said her most cherished roles remained those of wife, mother, and friend.
Public figures have lately spoken openly about their own cancer fights, from Lady A’s Charles Kelley announcing multiple myeloma after rib fractures led to blood tests to other sudden diagnoses that upend careers and families.
Shroff’s record shows a physician who treated clinical trials as a duty rather than an option and who kept building the next generation of research even after her own disease turned terminal. Another recent account of a young public figure confronting cancer came when Will Reeve revealed his testicular cancer fight and later said the disease was behind him.
Real medical progress still depends on people who refuse to quit when the data are thin and the odds are long.
